SBI Securities’s Q32 Bio QTTB Stock Holding History

SBI Securities’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.27K	Buy	154 +60	+64%	+$831	﹤0.01%	2770
2026 Q2	$1.2K	Sell	94 -10	-10%	-$84	﹤0.01%	2732
2026 Q1	$668	Sell	104 -53	-34%	-$252	﹤0.01%	2792
2025 Q4	$521	Sell	157 -7,999	-98%	-$22.6K	﹤0.01%	2862
2025 Q3	$16.1K	Buy	8,156 +1	+0%	+$2	﹤0.01%	1542
2025 Q2	$12.2K	Buy	8,155 +8,008	+5,448%	+$13.6K	﹤0.01%	1620
2025 Q1	$243	Sell	147 -91	-38%	-$245	﹤0.01%	3150
2024 Q4	$819	Buy	+238	New	+$7.52K	﹤0.01%	2698

Other funds holding QTTB

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

SBI Securities's QTTB Position: Q3 2026 in Review

SBI Securities increased its Q32 Bio (QTTB) stake by 64% in Q3 2026, buying an estimated $831 and bringing the position to 154 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #2770.

SBI Securities first reported a position in QTTB in Q4 2024 and has held it in 8 quarters since. The position peaked at $16.1K in Q3 2025. 3 funds tracked by Wall St. Rank hold QTTB as of Q3 2026.

SBI Securities held 154 shares of Q32 Bio worth $1.27K as of Q3 2026.
SBI Securities bought 60 Q32 Bio shares in Q3 2026, an estimated $831.
Q32 Bio made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2770 holding.
SBI Securities first reported a position in Q32 Bio in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Q32 Bio position peaked at $16.1K in Q3 2025.
3 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.